| Literature DB >> 24663085 |
Fa-Yan Meng1, Yuan-Ling Ning2, Jia Qi3, Zhou He4, Jiang Jie5, Juan-Juan Lin6, Yan-Jun Huang7, Fu-Sen Li8, Xue-Hua Li9.
Abstract
A new water-soluble polysaccharide (longan polysaccharide 1 (LP1)) was extracted and successfully purified from Dimocarpus longan pulp via diethylaminoethyl (DEAE)-cellulose anion-exchange and Sephacryl S-300 HR gel chromatography. The chemical structure was determined using Infrared (IR), gas chromatography (GC) and nuclear magnetic resonance (NMR) analysis. The results indicated that the molecular weight of the sample was 1.1 × 10(5) Da. Monosaccharide composition analysis revealed that LP1 was composed of Glc, GalA, Ara and Gal in a molar ratio of 5.39:1.04:0.74:0.21. Structural analysis indicated that LP1 consisted of a backbone of → 4)-α-D-Glcp-(1 → 4)-α-D-GALPA-(1 → 4)-α-D-Glcp-(1 → 4)-β-D-Glcp-(1 → units with poly saccharide side chains composed of → 2)-β-D-Fruf-(1 → 2)-L-sorbose-(1 → attached to the O-6 position of the α-D-Glcp residues. In vitro experiments indicated that LP1 had significantly high antitumor activity against SKOV3 and HO8910 tumor cells, with inhibition percentages of 40% and 50%, respectively. In addition, LP1 significantly stimulated the production of the cytokine interferon-γ (IFN-γ), increased the activity of murine macrophages and enhanced B- and T-lymphocyte proliferation. The results of this study demonstrate that LP1 has potential applications as a natural antitumor agent with immunomodulatory activity.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24663085 PMCID: PMC3975445 DOI: 10.3390/ijms15035140
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1.Determination of the molecular weight (Mr) of longan polysaccharide 1 (LP1) via high-performance gel permeation chromatography (HPGPC).
Figure 2.(a) High-performance liquid chromatography (HPLC) of standard monosaccharides; and (b) HPLC of LP1 after complete acid hydrolysis. PMP, 1-phenyl-3-methyl-5-pyrazolone.
Figure 3.Fourier transform infrared (FT-IR) spectrum of LP1.
Figure 4.1H NMR spectrum of LP1.
Figure 5.13C NMR spectrum of LP1.
Figure 6.DEPT135 spectrum of LP1.
Figure 7.HMBC spectrum of LP1.
1H NMR and 13C NMR shifts of LP1 and their assignments.
| Glycosyl residues | H-1/C-1 | H-2/C-2 | H-3/C-3 | H-4/C-4 | H-5/C-5 | H-6a, H-6b/C-6 |
|---|---|---|---|---|---|---|
| →4)-α- | 5.27/92.11 | 3.42/70.99 | 3.56/72.85 | 3.89/73.84 | 3.74/75.81 | 3.66,3.64/60.65 |
| 5.09/92.00 | 3.40/70.99 | 3.56/72.85 | 3.87/74.24 | 3.77/72.46 | 3.67, 3.57/60.55 | |
| →4,6)-β- | 4.51/95.79 | 3.12/73.78 | 3.34/75.51 | 3.75/72.12 | 3.58/72.46 | 3.86,3.92/63.28 |
| →2)-β- | 3.56,3.74/63.78 | –/103.59 | 4.07/76.23 | 3.92/74.57 | 3.74/81.27 | 3.64,3.59/62.99 |
| →2)- | 3.56,3.66/64.04 | –/98.03 | 3.70/70.99 | 3.56/74.33 | 3.52/71.03 | 3.75,3.59/62.35 |
HMBC data and assignments of LP1.
| Glycosyl residues | δH/δC atom | Observed connectivities |
|---|---|---|
|
| ||
| δH/δC atom | ||
| A→4)-α- | 5.27 A-H1 | 72.12 B-C4 |
| A′→4)-α- | 5.09 A′-H1 | 71.11 |
| B→4,6)-β- | 4.51 B-H1 | – |
| C→2)-β- | 103.41 C-C2 | 3.56 D-H1 |
| D→2)- | 98.03 D-C2 | 3.56 D-H3 3.86 B-H6 |
Cytotoxicity of LP1 in SKOV3 tumor cells after 48 h (χ̄ ± SD, n = 6). χ̄ ± SD: the means of six determinations.
| Group | Concentration (mg/L) | Inhibition (%) | |
|---|---|---|---|
| Control | – | 0.799 ± 0.005 | 0 |
| 5-Fluorouracil (5-FU) | 5 | 0.350 ± 0.018 | 56.2 |
| LP1 | 40 | 0.480 ± 0.017 | 39.9 |
| 20 | 0.494 ± 0.007 | 38.2 | |
| 10 | 0.496 ± 0.005 | 37.9 | |
| 5 | 0.504 ± 0.002 | 36.9 |
Versus the control group:
p < 0.01.
Cytotoxicity of LP1 in HO8910 tumor cells after 72 h (χ̄ ± SD, n = 6).
| Group | Concentration (mg/L) | Inhibition (%) | |
|---|---|---|---|
| Control | – | 0.610 ± 0.006 | 0 |
| 5-FU | 5 | 0.284 ± 0.007 | 53.4 |
| LP1 | 320 | 0.303 ± 0.008 | 50.3 |
| 160 | 0.328 ± 0.004 | 46.2 | |
| 80 | 0.330 ± 0.006 | 45.9 | |
| 40 | 0.355 ± 0.008 | 41.8 |
Versus the control group:
p < 0.01.
Effect of LP1 on macrophage phagocytic ability in vitro (χ̄ ± SD, n = 6). LPS, lipopolysaccharide.
| Group | Concentration (μg/mL) | Phagocytic count (OD570 nm) |
|---|---|---|
| Blank control group | – | 0.184 ± 0.0071 |
| LPS-positive group | 10 | 0.306 ± 0.0167 |
| LP1 | 25 | 0.293 ± 0.0128 |
| 50 | 0.312 ± 0.0132 | |
| 100 | 0.329 ± 0.0097 |
Compared with the normal control, p < 0.05.
Effect of LP1 on NO production by mouse peritoneal macrophages (χ̄ ± SD, n = 6).
| Group | Concentration (μg/mL) | NO production (μM) |
|---|---|---|
| Blank control group | – | 7.51 ± 0.781 |
| LPS-positive group | 10 | 25.05 ± 1.082 |
| LP1 | 25 | 18.85 ± 1.012 |
| 50 | 20.75 ± 0.976 | |
| 100 | 22.85 ± 0.998 |
Compared with the normal control, p < 0.05.
Effect of LP1 on TNF-α secretion by mouse peritoneal macrophages (χ̄ ± SD, n = 6).
| Group | Concentration (μg/mL) | TNF-α concentration (pg/mL) |
|---|---|---|
| Blank control group | – | 172.85 ± 17.09 |
| LPS-positive group | 10 | 560.65 ± 34.31 |
| LP1 | 25 | 427.65 ± 22.64 |
| 50 | 451.22 ± 26.98 | |
| 100 | 497.65 ± 24.46 |
Compared with the normal control, p < 0.05.
Effect of LP1 on IL-6 secretion by mouse peritoneal macrophages (χ̄ ± SD, n = 6).
| Group | Concentration (μg/mL) | IL-6 concentration (pg/mL) |
|---|---|---|
| Blank control group | – | 20.13 ± 1.69 |
| LPS-positive group | 10 | 59.55 ± 4.19 |
| LP1 | 25 | 68.65 ± 3.64 |
| 50 | 72.92 ± 4.08 | |
| 100 | 78.85 ± 3.86 |
Compared with the normal control, p < 0.05;
compared with the LPS-positive control, p < 0.05.
Effect of LP1 on IL-1β secretion by mouse peritoneal macrophages (χ̄ ± SD, n = 6).
| Group | Concentration (μg/mL) | IL-1β concentration (pg/mL) |
|---|---|---|
| Blank control group | – | 34.51 ± 2.89 |
| LPS-positive group | 10 | 64.35 ± 4.04 |
| LP1 | 25 | 54.87 ± 3.12 |
| 50 | 58.17 ± 2.88 | |
| 100 | 64.14 ± 3.49 |
Compared with the normal control, p < 0.05.
Figure 8.Effect of the LP1 polysaccharide from Dimocarpus longan pulp on the cyclophosphamide (CY)-induced immunosuppression of serum IL-2 levels in mice (χ̄ ± SD, n = 8).
Figure 9.Effect of the LP1 polysaccharide from Dimocarpus longan pulp on cyclophosphamide (CY)-induced immunosuppression of serum IFN-γ levels in mice (χ̄ ± SD, n = 8) (* compared with CY, p < 0.05).
Figure 10.The effects of the LP1 polysaccharide from Dimocarpus longan pulp on cyclophosphamide (CY)-induced immunosuppression of the phagocytic ability of peritoneal macrophages as measured with neutral red (χ̄ ± SD, n = 8) (* compared with CY alone, p < 0.05).
Effect of the LP1 polysaccharide from Dimocarpus longan pulp on cyclophosphamide (CY)-induced immunosuppression of mouse splenic B-cell proliferation (χ̄ ± SD, n = 8).
| Group | Stimulus index 100% | ||
|---|---|---|---|
|
| |||
| LPS stimulated | No LPS stimulation | ||
| Control | 0.321 ± 0.08 | 0.276 ± 0.10 | 116 |
| CY | 0.243 ± 0.03 | 0.226 ± 0.13 | 108 |
| CY + LP1 (I) | 0.932 ± 0.34 | 0.637 ± 0.15 | 146 |
| CY + LP1 (II) | 0.856 ± 0.35 | 0.681 ± 0.08 | 126 |
| CY + LP1 (III) | 0.810 ± 0.24 | 0.673 ± 0.15 | 120 |
Compared with CY, p < 0.05.
Effect of the LP1 polysaccharide from Dimocarpus longan pulp on cyclophosphamide (CY)-induced immunosuppression of mouse splenic T-cell proliferation (χ̄ ± SD, n = 8).
| Group | Stimulus index 100% | ||
|---|---|---|---|
|
| |||
| ConA stimulated | No ConA stimulation | ||
| Control | 0.358 ± 0.05 | 0.276 ± 0.10 | 130 |
| CY | 0.263 ± 0.02 | 0.226 ± 0.13 | 116 |
| CY + LP1 (I) | 0.914 ± 0.13 | 0.637 ± 0.15 | 143 |
| CY + LP1 (II) | 0.849 ± 0.28 | 0.681 ± 0.08 | 125 |
| CY + LP1 (III) | 0.804 ± 0.21 | 0.673 ± 0.15 | 119 |
Compared with CY, p < 0.05.